NCT07231354

Brief Summary

This study investigates whether a structured physiotherapy program can help reduce symptoms of stress, anxiety, and depression in children and adolescents diagnosed with Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD). ASD and ADHD are neurodevelopmental conditions often associated with emotional and behavioral challenges, including elevated levels of psychological distress. The physiotherapy intervention includes techniques such as diaphragmatic breathing, acupressure, relaxation exercises, proprioceptive activities, and therapeutic positions designed to support emotional regulation. Children aged 6-18 years are randomly assigned to either an intervention group receiving the physiotherapy program or a control group receiving usual care. The purpose of the study is to evaluate whether this physiotherapy protocol can positively influence emotional well-being and behavioral indicators related to ASD and ADHD. Outcomes are assessed using validated questionnaires measuring stress, anxiety, depression, and disorder-related behavioral characteristics before and after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2023

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

November 13, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 17, 2025

Completed
Last Updated

November 17, 2025

Status Verified

November 1, 2025

Enrollment Period

1 year

First QC Date

November 13, 2025

Last Update Submit

November 13, 2025

Conditions

Keywords

PhysiotherapyMental HealthChildrenAdolescentsExercise TherapyRehabilitation

Outcome Measures

Primary Outcomes (3)

  • Change in Stress Levels (DASS-21 Stress Subscale)

    Stress levels assessed using the DASS-21 Stress Subscale (score range 0-42). Higher scores indicate higher stress. The outcome will be analyzed as the change in score from baseline to post-intervention.

    Baseline and post-intervention (after 10 sessions - approximately 5 weeks)

  • Change in Anxiety Levels (DASS-21 Anxiety Subscale)

    Stress/anxiety levels assessed using the DASS-21 Anxiety Subscale (score range 0-42). Higher scores indicate greater anxiety symptoms. The outcome will be analyzed as the change in score from baseline to post-intervention.

    Baseline and post-intervention (after 10 sessions - approximately 5 weeks)

  • Change in Depression Levels (DASS-21 Depression Subscale)

    Depression levels assessed using the DASS-21 Depression Subscale (score range 0-42). Higher scores indicate higher depressive symptoms. The outcome will be analyzed as the change in score from baseline to post-intervention.

    Baseline and post-intervention (after 10 sessions - approximately 5 weeks)

Secondary Outcomes (2)

  • Change in Autism-Related Behavioral Indicators (CAST Score)

    Baseline and post-intervention (after 10 sessions - approximately 5 weeks)

  • Change in ADHD-Related Behavioral Indicators (ADHD Parent Questionnaire Score)

    Baseline and post-intervention (after 10 sessions - approximately 5 weeks)

Study Arms (2)

Physiotherapy Intervention Group

EXPERIMENTAL

Participants receive a structured physiotherapy program designed to improve emotional regulation, reduce anxiety symptoms, and enhance overall mental health. The program includes sensorimotor exercises, coordination training, postural activities, and structured physical activity tailored to children and adolescents with ASD or ADHD.

Behavioral: Structured Physiotherapy Program

Comparator Group

NO INTERVENTION

Participants do not receive physiotherapy during the study period but continue their usual daily routines. After study completion, they are offered the physiotherapy program.

Interventions

A structured multimodal physiotherapy program including sensorimotor integration exercises, balance and coordination training, postural control activities, therapeutic physical activity, breathing regulation techniques, and proprioceptive stimulation. The intervention is tailored to children and adolescents with ASD or ADHD and aims to improve emotional regulation, reduce anxiety, enhance behavioral self-control, and promote overall mental health.

Physiotherapy Intervention Group

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of Autism Spectrum Disorder (ASD) or Attention Deficit Hyperactivity Disorder (ADHD) by a qualified clinician.
  • Age between 6 and 18 years.
  • Ability to participate in structured physiotherapy sessions.
  • Stable medication regimen (if applicable) for at least 4 weeks prior to study entry.
  • Parent/guardian consent and child assent (where applicable).
  • Ability of parents/guardians to comply with study procedures and assessments.

You may not qualify if:

  • Severe intellectual disability that prevents participation in physiotherapy activities.
  • Uncontrolled epilepsy or other neurological disorders that pose safety risks.
  • Severe sensory or motor impairments preventing safe exercise participation.
  • Participation in another clinical study within the last 3 months.
  • Any acute medical condition deemed unsafe for physical activity.
  • Behavioral issues that prevent structured participation (e.g., aggressive behavior).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hippokratio General Hospital of Thessaloniki - Child Psychiatry Department

Thessaloniki, 546 42, Greece

Location

MeSH Terms

Conditions

Autism Spectrum DisorderAttention Deficit Disorder with HyperactivityNeurodevelopmental DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveMental DisordersAttention Deficit and Disruptive Behavior DisordersPersonal SatisfactionBehavior

Study Officials

  • Illias Kallistratos

    International Hellenic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessor was blinded to group assignment to minimize assessment bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two-arm parallel-group randomized controlled design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 13, 2025

First Posted

November 17, 2025

Study Start

June 28, 2022

Primary Completion

July 15, 2023

Study Completion

July 15, 2023

Last Updated

November 17, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Participant-level data will not be shared in order to protect confidentiality, as the dataset includes sensitive information from children and adolescents

Locations